• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . A two-step mechanism for RIG-I activation by influenza virus mvRNAs

tetano

Editor, Senior Moderator
Sci Adv


. 2025 Aug 8;11(32):eadw8034.
doi: 10.1126/sciadv.adw8034. Epub 2025 Aug 8. A two-step mechanism for RIG-I activation by influenza virus mvRNAs

Emmanuelle Pitré[SUP] 1 2 [/SUP], Karishma Bisht[SUP] 1 [/SUP], Kaleigh A Remick[SUP] 1 [/SUP], Amir Ghorbani[SUP] 3 [/SUP], Jonathan W Yewdell[SUP] 3 [/SUP], Elizaveta Elshina[SUP] 1 2 [/SUP], Aartjan J W Te Velthuis[SUP] 1 [/SUP]



Affiliations
Abstract

Influenza A virus (IAV) noncanonical RNAs are bound by retinoic acid-inducible gene I (RIG-I). However, innate immune activation is infrequent and it is not understood why noncanonical IAV RNAs activate RIG-I in a sequence- or RNA structure-dependent manner. We hypothesized that multiple events need to occur before IAV RNA synthesis activates RIG-I and investigated whether RIG-I activation is stimulated by the noncanonical or aberrant transcription of mini viral RNAs (mvRNA), an RNA that is overexpressed in highly pathogenic IAV infections. We find that mvRNAs can cause noncanonical transcription termination through a truncated 5' polyadenylation signal or a 5' transient RNA structure that interrupts polyadenylation. The resulting capped complementary RNAs stimulate the release of an mvRNA and complement RIG-I activation in trans. Overall, our findings indicate that sequential rounds of noncanonical or aberrant viral replication and transcription are needed for innate immune signaling by IAV RNA synthesis.


 
Back
Top